The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection

Nature Medicine

Volumn 12, Issue 6, 2006, Pages 636-641

  Chromek, Milan ^a   Slamová, Zuzana ^a   Bergman, Peter ^b   Kovács, László ^c   Podracká, L'udmila ^d   Ehrén, Ingrid ^a   Hökfelt, Tomas ^b   Gudmundsson, Gudmundur H ^e   Gallo, Richard L ^f   Agerberth, Birgitta ^b   Brauner, Annelie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^d Med Faculty of Safarik University   (Slovakia)

^e UNIVERSITY OF ICELAND   (Iceland)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHELIN RELATED ANTIMICROBIAL PEPTIDE; CATIONIC ANTIMICROBIAL PEPTIDE 18; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL CONTACT; CELL LOSS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; DISEASE SEVERITY; DRUG EFFECT; DRUG SENSITIVITY; EPITHELIUM; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNITY; MOUSE; MUCOSA; NEUTROPHIL; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTECTION; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PYELONEPHRITIS; URINARY TRACT; URINARY TRACT INFECTION; URINE; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CHILD; DRUG RESISTANCE, BACTERIAL; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; IMMUNITY, MUCOSAL; KIDNEY CORTEX; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIAL SENSITIVITY TESTS; NEUTROPHILS; URINARY TRACT; URINARY TRACT INFECTIONS; UROTHELIUM;

BACTERIA (MICROORGANISMS);

EID: 33744986714     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1407     Document Type: Article

References (45)

1. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389-395 (2002).
2. Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720 (2003).
3. Zanetti, M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39-48 (2004).
4. Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457 (2001).
5. Moser, C. et al. β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70, 3068-3072 (2002).
6. Valore, E.V. et al. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101, 1633-1642 (1998).
7. Morrison, G., Kilanowski, F., Davidson, D. & Dorin, J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect. Immun. 70, 3053-3060 (2002).
8. Zucht, H.D. et al. Human β-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. Eur. J. Med. Res. 3, 315-323 (1998).
9. Zaiou, M. & Gallo, R.L. Cathelicidins, essential gene-encoded mammalian antibiotics. J. Mol. Med. 80, 549-561 (2002).
10. Tollin, M. et al. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24, 523-530 (2003).
11. Agerberth, B. et al. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med. 160, 283-290 (1999).
12. Gudmundsson, G.H. et al. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238, 325-332 (1996).
13. Malm, J. et al. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect. Immun. 68, 4297-4302 (2000).
14. Gallo, R.L. et al. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem. 272, 13088-13093 (1997).
15. Sorensen, O.E. et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951-3959 (2001).
16. Zaiou, M., Nizet, V. & Gallo, R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J. Invest. Dermatol. 120, 810-816 (2003).
17. Pestonjamasp, V.K., Huttner, K.H. & Gallo, R.L. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides 22, 1643-1650 (2001).
18. Brogden, K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250 (2005).
19. Scott, M.G., Davidson, D.J., Gold, M.R., Bowdish, D. & Hancock, R.E. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169, 3883-3891 (2002).
20. Yang, D., Biragyn, A., Kwak, L.W. & Oppenheim, J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23, 291-296 (2002).
21. Bowdish, D.M., Davidson, D.J. & Hancock, R.E. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6, 35-51 (2005).
22. Turner, J., Cho, Y., Dinh, N.N., Waring, A.J. & Lehrer, R.I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206-2214 (1998).
23. Faurschou, M. & Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5, 1317-1327 (2003).
24. Hase, K., Eckmann, L., Leopard, J.D., Varki, N. & Kagnoff, M.F. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70, 953-963 (2002).
25. Norden, C.W., Green, G.M. & Kass, E.H. Antibacterial mechanisms of the urinary bladder. J. Clin. Invest. 47, 2689-2700 (1968).
26. Justice, S.S. et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA 101, 1333-1338 (2004).
27. Gordon, D.M. & Riley, M.A. A theoretical and experimental analysis of bacterial growth in the bladder. Mol. Microbiol. 6, 555-562 (1992).
28. Cox, C.E. & Hinman, F., Jr. Experiments with induced bacteriuria, vesical emptying and bacterial growth on the mechanism of bladder defense to infection. J. Urol. 86, 739-748 (1961).
29. Mulvey, M.A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494-1497 (1998).
30. Bates, J.M. et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 65, 791-797 (2004).
31. Fliedner, M., Mehls, O., Rauterberg, E.W. & Ritz, E. Urinary slgA in children with urinary tract infection. J. Pediatr. 109, 416-421 (1986).
32. Abrink, M., Larsson, E., Gobl, A. & Hellman, L. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int. 57, 2004-2010 (2000).
33. Islam, D. et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7, 180-185 (2001).
34. Bergman, P. et al. Neisseria gonorrhoeas downregulates expression of the human antimicrobial peptide LL-37. Cell. Microbiol. 7, 1009-1017 (2005).
35. Johansson, J., Gudmundsson, G.H., Rottenberg, M.E., Berndt, K.D. & Agerberth, B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273, 3718-3724 (1998).
36. Sorensen, O., Arnljots, K., Cowland, J.B., Bainton, D.F. & Borregaard, N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90, 2796-2803 (1997).
37. Dorschner, R.A. et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 20, 35-42 (2006).
38. Yan, H. & Hancock, R.E. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 45, 1558-1560 (2001).
39. Braff, M.H., Zaiou, M., Fierer, J., Nizet, V. & Gallo, R.L. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect. Immun. 73, 6771-6781 (2005).
40. Yoshio, H. et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr. Res. 53, 211-216 (2003).
41. Todd, J.H., McMartin, K.E. & Sens, D.A. Enzymatic isolation and serum-free culture of human renal cells, in Human cell culture protocols (ed. Jones, G.E.) 431-436 (Humana Press, Totowa, 1996).
42. Rossi, M.R. et al. The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ. Health Perspect. 109, 801-808 (2001).
43. Khalil, A. et al. Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J. Urol. 158, 1576-1580 (1997).
44. Chromek, M. et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring. Pediatr. Res. 53, 698-705 (2003).
45. Black, C.A. et al. Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Infect. Immun. 66, 1273-1275 (1998).